Rekah Pharmaceuticals, a significant player in Israel’s pharmaceutical industry with a market value of about $37 million, recently experienced a disruptive cyber attack. The incident prompted the company to suspend its distribution system, managed by subsidiary Ophir & Shalpharm Medicines and Cosmetics, following the detection of unauthorized access to their computer systems. CEO Mordechai Algrably confirmed the intrusion and emphasized the company’s proactive response, which included shutting down compromised systems and deploying a specialized team of external cybersecurity experts to contain and mitigate the attack.
The immediate priority for Rekah Pharmaceuticals is to restore the functionality of its distribution system swiftly. Algrably highlighted ongoing efforts to explore manual alternatives to ensure minimal disruption to operations while the investigation and recovery efforts continue. Despite the setback, Algrably reassured stakeholders that the company’s production systems remain unaffected, enabling continued manufacturing of essential medicines, cosmetics, vitamins, and nutritional supplements.
While the cyber attack has temporarily halted distribution operations, Rekah Pharmaceuticals remains focused on minimizing the impact on its supply chain and customer commitments. Algrably acknowledged that the incident may cause short-term inconvenience but underscored the company’s dedication to resolving the issue promptly and efficiently. He emphasized the importance of maintaining operational integrity and ensuring that measures are in place to prevent future cybersecurity threats.
Looking ahead, Rekah Pharmaceuticals is evaluating contingency plans to mitigate potential risks associated with prolonged system disruptions. The company aims to restore normal distribution operations swiftly, leveraging both technological and manual solutions to meet the needs of pharmacies, hospitals, and other customers who rely on its products. Through these efforts, Rekah Pharmaceuticals strives to uphold its reputation for reliability and quality in the face of cybersecurity challenges.
